The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
Travel, Accommodations, Expenses - Kadmon
Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in advanced solid tumors.
 
Jason J. Luke
Stock and Other Ownership Interests - Actym Therapeutics; Alphamab; Arch Oncology; Kanaph Therapeutics; Mavu Pharmaceutical; Onc.AI; Pyxis; Tempest Therapeutics
Consulting or Advisory Role - 7 Hills Pharma; Abbvie; Alphamab; Array BioPharma; Astellas Pharma; Bayer; Bristol-Myers Squibb; Checkmate Pharmaceuticals; Compugen; CStone Pharmaceuticals; Eisai; EMD Serono; Incyte; Janssen; Merck; Mersana; Nektar; Novartis; Partner Therapeutics; Reflexion Medical; Regeneron; Ribon Therapeutics; Rubius Therapeutics; Spring Bank; Synlogic; Tempest Therapeutics; Tesaro; TTC Oncology; Werewolf Therapeutics; Xencor; Xilio Therapeutics
Research Funding - Abbvie (Inst); Agios; Array BioPharma; Astellas Pharma; Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals; Corvus Pharmaceuticals (Inst); EMD Serono; Immatics; Incyte (Inst); Kadmon; Macrogenics (Inst); Merck (Inst); Moderna Therapeutics; Nektar; Spring bank; Trishula Therapeutics; Xencor (Inst)
Patents, Royalties, Other Intellectual Property - Serial #15/612,657 (Cancer Immunotherapy),; Serial #PCT/US18/36052 (Microbiome Biomarkers for Anti-PD-1/PD-L1 Responsiveness: Diagnostic, Prognostic and Therapeutic Uses Thereof)
Travel, Accommodations, Expenses - Array BioPharma; Bristol-Myers Squibb; EMD Serono; Janssen; Merck; Mersana; Novartis; Pyxis; Reflexion Medical; Xilio Therapeutics
 
Anthony J. Olszanski
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer; Sanofi
Research Funding - Alkermes (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); Gan & Lee (Inst); GlaxoSmithKline (Inst); Glyconex (Inst); Immunocore (Inst); Intensity Therapeutics (Inst); Iovance Biotherapeutics (Inst); Kadmon (Inst); Kartos Therapeutics (Inst); Navire (Inst); Nektar (Inst); OncoSec (Inst); Regeneron (Inst); Seagen (Inst); Sound Biologics (Inst); Spring Bank (Inst); Sumitomo Group (Inst); Takeda (Inst); Targovax (Inst)
(OPTIONAL) Uncompensated Relationships - Takeda
 
Igor Puzanov
Stock and Other Ownership Interests - Celldex; Celldex (I)
Consulting or Advisory Role - Amgen; Iovance Biotherapeutics; Merck; Roche
 
Dan Lu
Employment - Alvogen (I); Kadmon
Stock and Other Ownership Interests - Kadmon; Lilly; Teva (I)
Patents, Royalties, Other Intellectual Property - Flt-3 antibody (Inst); PD1 antibody and I15 fusions (Inst); PDL1 antibody and fusions (Inst); VEGFR2 antibody (Inst)
 
Adrian Hackett
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
 
Stella Martomo
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
Honoraria - Kadmon
Research Funding - Kadmon
Patents, Royalties, Other Intellectual Property - Patent
Travel, Accommodations, Expenses - Kadmon
 
Jeegar Patel
Employment - Kadmon
Stock and Other Ownership Interests - Kadmon
Travel, Accommodations, Expenses - Kadmon
 
Olivier Schueller
Employment - Kadmon
 
Alessandro Mora
Employment - Jounce Therapeutics; Kadmon
Stock and Other Ownership Interests - Jounce Therapeutics; Kadmon
Travel, Accommodations, Expenses - Jounce Therapeutics
 
Miranda Schlitt
Employment - Kadmon
Research Funding - Kadmon (Inst)
Travel, Accommodations, Expenses - Kadmon
 
Linghui Li
No Relationships to Disclose